as on November 21, 2025 at 2:29 am IST
Day's Low
Day's High
0.17%
Downside
8.33%
Upside
52 Week's Low
52 Week's High
54.37%
Downside
15.30%
Upside
Check Rhythm Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.7B
EPS (TTM)
-3.043
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.86
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
-184.8M
Revenue (TTM)
174.3M
Profit Margin
-110.32%
Return On Equity TTM
-85.79%
Track how Rhythm Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Rhythm Pharmaceuticals Inc in the last 5 years
Lowest (-40.72x)
September 30, 2025
Today (-10.86x)
November 20, 2025
Industry (8.36x)
November 20, 2025
Highest (-1.56x)
June 30, 2022
Today’s Price to Earnings Ratio: -10.86x
Compare market cap, revenue, PE, and other key metrics of Rhythm Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $6.7B | NA | -10.86 | -110.32% | |
| BUY | $43.4B | 421.01% | -16.34 | -264.83% | |
| BUY | $61.1B | 269.49% | 1651.07 | 1.36% | |
| BUY | $111.7B | 95.64% | 30.67 | 31.35% | |
| BUY | $76.9B | 35.47% | 17.39 | 32.13% |
The Rhythm Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rhythm Pharmaceuticals Inc investment value today
Current value as on today
₹1,74,662
Returns
₹74,662
(+74.66%)
Returns from Rhythm Pharmaceuticals Inc Stock
₹69,491 (+69.49%)
Dollar Returns*
₹5,171 (+5.17%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Rhythm Pharmaceuticals Inc. Average target price of $126.31
Get share price movements and forecasts by analysts on Rhythm Pharmaceuticals Inc.
What analysts predicted
20.35%UPSIDE
Target Price
$126.31
Current Price
$100.61
Analyzed by
15 Analysts
Target
$126.31
Rhythm Pharmaceuticals Inc target price $126.31, a slight upside of 20.35% compared to current price of $100.61. According to 15 analysts rating.
Search interest for Rhythm Pharmaceuticals Inc Stock has increased by 57% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:57% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 05 November
Wed, 10:30 AM
-Rhythm Pharmaceuticals reports Q3 2025 revenue of $51.3 million, a 6% increase, but a net loss of $54.3 million.
Thu, 07:12 AM
-Rhythm Pharmaceuticals highlights growth, regulatory progress, and plans for IMCIVREE launch with a PDUFA date set for December 20, 2025.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 32.70M → 51.29M (in $), with an average increase of 19.0% per quarter
Price Rise
![]()
In the last 7 days, RYTM stock has moved up by 7.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 943.9% return, outperforming this stock by 641.3%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 180.1% return, outperforming this stock by 106.3%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -46.63M → -52.90M (in $), with an average decrease of 13.5% per quarter
| Organisation | Rhythm Pharmaceuticals Inc |
| Headquarters | 222 Berkeley Street, Boston, MA, United States, 02116 |
| Industry | Health Technology |
| CEO | Dr. David P. Meeker M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. David P. Meeker M.D. | Chairman, President & CEO |
Mr. Joseph Shulman | Chief Technical Officer |
Mr. Jim Flaherty | Senior VP & General Counsel |
Ms. Sarah Ryan | Vice President of Sales & Marketing |
Mr. Hunter C. Smith M.B.A. | CFO & Treasurer |
Mr. Yann Mazabraud | Executive VP & Head of International |
Ms. Jennifer Lee | Executive VP & Head of North America |
Mr. Christopher P. German | Corporate Controller & Principal Accounting Officer |
Dr. Alastair Garfield Ph.D. | Chief Scientific Officer |
Mr. David Connolly | Head of Investor Relations & Corporate Communications |
Rhythm Pharmaceuticals Inc share price today is $100.61 as on at the close of the market. Rhythm Pharmaceuticals Inc share today touched a day high of $108.99 and a low of $100.44.
Rhythm Pharmaceuticals Inc share touched a 52 week high of $116 on and a 52 week low of $45.91 on . Rhythm Pharmaceuticals Inc stock price today i.e. is closed at $100.61,which is 13.27% down from its 52 week high and 119.17% up from its 52 week low.
Rhythm Pharmaceuticals Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Rhythm Pharmaceuticals Inc (RYTM) shares with as little as ₹88.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.80 in Rhythm Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rhythm Pharmaceuticals Inc share’s latest price of $100.61 as on November 21, 2025 at 2:29 am IST, you will get 0.0994 shares of Rhythm Pharmaceuticals Inc. Learn more about
fractional shares .